November 2020 Vol 11, No 11

With high recurrence and mortality rates, ovarian cancer often has a devastating impact on patients and their loved ones.
The National Accreditation Program for Breast Centers (NAPBC)/American College of Surgeons is dedicated to promoting improved treatment outcomes for breast disease.
The “Moving On” Oncology Rehabilitation program is a free 12-week exercise program for cancer survivors located at the Prisma Health Cancer Institute Center for Integrative Oncology & Survivorship.
Sylvester Comprehensive Cancer Center (SCCC) at the University of Miami is 1 of only 2 cancer centers that have been recognized by the National Cancer Institute in Florida.
Early-stage and hormone receptor–positive breast cancers may need additional genomic testing to determine which patients need chemotherapy in addition to endocrine therapy.
Cancer patients with bone metastasis or multiple myeloma (MM) are at increased risk for painful and irreversible bone complications known as skeletal- related events (SREs), which include bone fractures, spinal cord compression, and radiation or surgery to the bone.
As a member of the Cancer Care Committee at a community hospital, the thoracic oncology nurse navigator (ONN) recognized the need for a quality study investigating the process for cancer patients receiving PEG tube placement.
A professional steering committee for Great Lakes Health Hospital System identified the need to coordinate and integrate an organized oncology service line and attain Commission on Cancer accreditation.
The first cases of COVID-19 in the United States were reported in early January 2020 and began rapidly increasing in March 2020.
Oncology nurse navigators and administrative staff reported spending more than half their daily shifts in some way managing incoming calls and the backlog of voicemails.
This year, there are no accepted abstracts within this research category.
Clinical pathways have increasingly been incorporated into cancer care, aiming to encourage high-quality, evidence-based care while minimizing costs; however, clinical pathways infrequently incorporate patient and family perspectives, limiting patient-centeredness and value for shared decision-making.
Ibrutinib is the only once-daily Bruton tyrosine kinase inhibitor that has shown significant progression-free survival (PFS) and overall survival (OS) benefits in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) across multiple randomized phase 3 studies.
The UT Southwestern Cancer Genetics Program implemented a genetic patient navigator (GPN) to assess patients’ barriers to care, assist patients in identifying resources to increase compliance, promote healthy lifestyle education, and assist with coordination of cascade testing for at-risk relatives.
The use of acuity scales to assess cancer patient needs when undergoing treatment is gaining recognition as a way to optimize caseloads for patient navigators (PNs).
A 21-year-old with carcinoma of the nasopharynx was first evaluated by the Head and Neck Oncology Service at Memorial Sloan Kettering Cancer Center (MSKCC) in April 2020.
The process of screening and/or detection to the actual diagnosis of lung cancer involves multiple specialties and diagnostic testing, which can be quite daunting for an individual and his/her family.
Page 1 of 2
Results 1 - 30 of 42

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State

    Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code
    Country